The global breast biopsy devices industry growth is poised for exceptional growth, projecting a Compound Annual Growth Rate (CAGR) of approximately 5.5% from 2022 to 2032. Future Market Insights (FMI) forecasts the market value to soar to US$ 3.6 Billion by 2032, a substantial surge from its US$ 2.1 billion valuation in 2022. The latest …